8th Edition MarketsandMarkets Biomarker and Companion Diagnostics Virtual Conference ( Time Zone - CENTRAL EUROPEAN TIME (CET)

24th - 26th March 2021
Sponsors
Platinum

Larvol

Larvol

Committed to healthcare since 2004, LARVOL has been delivering custom intelligence solutions that provide healthcare and life sciences experts accurate, rapid, expertly-curated information to enable strategic decision-making. Specifically in the oncology space, we collate and simplify data from over 25,000 sources and offer novel tools to extract meaningful insights. Our newest product CLIN delivers the complete universe of immuno-oncology clinical trial data in one, easy-to-navigate platform. That's ten years of trial data, manually reviewed and coded to extract every table, graph, and figure. New data is added as it's released from publications, conferences, and guidelines.


NeoGenomics

NeoGenomics

NeoGenomics is an industry-leading cancer diagnostics and pharma services company. We enable advanced oncology patient care leveraging the most extensive diagnostic solid tumor and hematological test menus, sub-specialized pathology, and expertise in biomarker development. We partner closely with our pharma and research clients to meet program objectives and delivery from biomarker discovery through CDx validation and commercialization.


Agilent

Agilent

Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets. With over 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions.

Agilent brings the power of precision medicine to customers, partners, and patients.  Agilent is a partner of choice to pharmaceutical and biotech companies producing innovative diagnostics and therapeutics for the benefit of patients around the world.


QIAGEN

QIAGEN

Every day, QIAGEN serves 500,000 customers globally, all seeking insights from DNA and RNA. Delivering Sample to Insight solutions for molecular testing, we help scientists and clinicians achieve breakthroughs in life sciences research, molecular diagnostics and drug development. This is how we make improvements in life possible. In healthcare and academic institutions, and drug-discovery and forensic laboratories, QIAGEN solutions advance disease detection and treatments, enable precision medicine, and aid crime detection and human identification.

Gold

Owlstone Medical

Owlstone Medical

Owlstone Medical’s mission is to save 100,000 lives and $1.5 billion in healthcare costs by realizing the potential of breath biomarkers for early detection and precision medicine through Breath Biopsy®. Breath Biopsy provides reliable solutions for the collection and analysis of volatile organic compounds (VOCs) produced through metabolic processes or as a result of interaction with external factors such as diet or medication. Changes to exhaled VOCs can be associated with a range of disease conditions and environmental exposures.

 


Proteome Sciences

Proteome Sciences

We are a CRO specialising in the analysis of proteins and their associated PTM’s via advanced Mass Spectrometry.  By using proprietary methodologies, we can detect up to 8,000 proteins per sample in Discovery mode and can offer multiplexed assays of up to 100 proteins/sample in a GCLP accredited Targeted assay.

With their proprietary bioinformatics software, these can be trimmed down to some tens of proteins that are either up-, or down-regulated with disease progression or drug treatment.

Silver

Abcam

Abcam

As a global life sciences company, Abcam identifies, develops, and distributes high-quality biological reagents and tools that are crucial to research, drug discovery and diagnostics. Working across the industry, the Company supports life scientists to achieve their mission, faster.

Abcam partners with life science organisations to co-create novel binders for use in drug discovery, in vitro diagnostics and therapeutics, driven by the Company’s proprietary discovery platforms and world-leading, antibody expertise.

Speaking Partner

Boston Healthcare

Boston Healthcare

Boston Healthcare believes that meaningful and sustained innovation in healthcare depends on identifying optimal pathways to commercial success.

Boston Healthcare is a global consulting firm focused on enabling companies to derive optimal value from innovative products and services that have the potential to transform standards of care and significantly improve health outcomes. We have aligned our services and expertise to assure that the innovators reshaping healthcare are rewarded for their efforts and commitment, and we tailor our approach to the product and specific characteristics of each geographic market.


HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

Headquartered in Tucson, Arizona, HTG is focused on accelerating precision medicine – from diagnosis to treatment – by harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.  HTG’s proprietary extraction-free RNA expression technology simplifies and automates complex, highly multiplexed gene expression profiling from solid and (biofluid) liquid samples, even when limited by amount and quality. HTG’s transcriptome and targeted panels are designed to enable biomarker profile assessment and gene signature development associated with disease state, treatment response and outcome.


Precision Antibody

Precision Antibody


Cellular Technology Limited

Cellular Technology Limited

Cellular Technology Limited (CTL) specializes in cell-mediated immunity as an all-in-one solution provider for standardized immune monitoring.  We offer a comprehensive platform of instrumentation, reagents and services including our industry leading Analyzers, the largest portfolio of ELISPOT/FluoroSpot kits, an extensive library of HLA-typed cryopreserved PBMC, CD8/CD4 positive antigen controls, novel whole-well image-based cytotoxicity assays and a CLIA-certified Contract Laboratory offering services including: cryopreservation of samples, GLP compliant testing (using ELISPOT, ELISA, NAb, FACS), and customized assay development/validation.

Meeting Partner

Burning Rock

Burning Rock

Burning Rock Dx specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. With the unique capability and experience in global trials, we seek partnerships to advance the field of companion diagnostics in order to achieve better patient outcomes.